Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology
K-Number: K172343 · 2017-10-23
Device Summary
Frequently Asked Questions
What is the Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology?
Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology is a medical device that received FDA 510(k) clearance on 2017-10-23. It is manufactured by Rti Surgical, Inc.. The 510(k) number is K172343.
When was Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology approved by the FDA?
Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology received FDA 510(k) clearance on 2017-10-23, under approval number K172343.
What company makes Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology?
Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology is manufactured by Rti Surgical, Inc..
What is the FDA product code for Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology?
The FDA product code for Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology is MAX.
Related Clinical Trials
Related PubMed Literature
Other Devices by Rti Surgical, Inc.
Related Devices (Code: MAX)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.